Management of the extrapyramidal manifestations of phenylketonuria with L-dopa

1 June 1983

journal article
case report
Published by BMJ in Archives of Disease in Childhood

Vol. 58 (6) , 457-458
https://doi.org/10.1136/adc.58.6.457

Abstract

We report on a patient with phenylketonuria who developed disabling extrapyramidal features that were successfully controlled with L-dopa. We recommend that all such patients are given a trial with this drug.

Keywords

RECOMMEND
DOPA
PHENYLKETONURIA WHO
SUCCESSFULLY CONTROLLED
EXTRAPYRAMIDAL MANIFESTATIONS
MANIFESTATIONS OF PHENYLKETONURIA
DEVELOPED DISABLING
DISABLING EXTRAPYRAMIDAL

This publication has 3 references indexed in Scilit:

Pathogenesis of phenylketonuria: Inhibition of dopa and catecholamine synthesis in patients with phenylketonuria
Clinica Chimica Acta; International Journal of Clinical Chemistry, 1972
Pediatric Progress
Clinical Pediatrics, 1963
THE VARIABILITY IN MANIFESTATIONS OF UNTREATED PATIENTS WITH PHENYLKETONURIA (PHENYLPYRUVIC ACIDURIA)
Pediatrics, 1957